Improvement in cholesterol emboli syndrome after iloprost therapy.
Elinav
Eran
E
Department of Medicine, Hadassah University Hospital, Mount Scopus, Jerusalem 91240, Israel.
Chajek-Shaul
Tova
T
Stern
Mirella
M
D000368:Aged; D000369:Aged, 80 and over; D002404:Catheterization; D017023:Coronary Angiography; D001026:Coronary Artery Bypass; D017700:Embolism, Cholesterol / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D016285:Iloprost / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000601:surgery; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D010975:Platelet Aggregation Inhibitors; D014665:Vasodilator Agents; D016285:Iloprost